Sino Biopharmaceutical LtdEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 5.06 HKD | 9,017 HKD | 4,19 HKD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - HKD | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 17.773.977.337 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Sino Biopharmaceutical Ltd
Mitarbeiter 21.435
Handelsplatz HK
Ticker Symbol 1177
IPO Datum 2000-09-29
Adresse Unit 09, Office Tower, Wan Chai, Hong Kong
Webseite https://www.sbpgroup.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Ms. Y. Y. Tse | Executive Chairwoman of the Board |
| 2 | Mr. S. Y. Tse | CEO & Executive Director |
| 3 | Mr. Ping Tse | Founder & Senior Executive Vice Chairman |
| 4 | Ms. Cheung Ling Cheng | Executive Vice Chairwoman of the Board |
| 5 | Mr. Hsin Tse | Senior VP & Executive Director |
| 6 | Mr. Song Jin | Vice President of Public Affairs & ESG |
| 7 | Ms. Xiaoyan Kang | Chief Medical Officer |
| 8 | Dr. Meng Liu M.D., Ph.D. | Head of Clinical Development for Chronic Diseases |
| 9 | Dr. Rongjun Liu Ph.D. | Head of Clinical Development for Autoimmune Diseases |
| 10 | Ms. Kuen Lai | Company Secretary |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.